JOHN PETER MCLAUGHLIN Insider Trading $PDLI PDL BIOPHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN PETER MCLAUGHLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN PETER MCLAUGHLIN. JOHN PETER MCLAUGHLIN is CEO in PDL BIOPHARMA, INC. ($PDLI) and Director in PDL BIOPHARMA, INC. ($PDLI) and President, CEO in PDL BIOPHARMA, INC. ($PDLI) and Director in ROCKWELL MEDICAL, INC. ($RMTI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Chief Executive Officer in ANESIVA, INC. ($CGTK) and President & CEO in ANESIVA, INC. ($CGTK) and Director in LENSAR, Inc. ($LNSR) and Director in Adverum Biotechnologies, Inc. ($AAVL).
JOHN PETER MCLAUGHLIN in PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN PETER MCLAUGHLIN: Director, President, CEO
Holdings: 477,934 shares
Current Value: $1,056,234
Latest Transaction: Dec 22 2020
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN PETER MCLAUGHLIN in PDL BIOPHARMA, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, CGTK, LNSR, PDLI, RMTI, SGEN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Sell | S | 2.61 | 277,934 | 724,574 | 200,000 | 477.9 K to 200 K (-58.15 %) |
| Dec 22 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Sell | S | 2.62 | 50,000 | 131,200 | 477,934 | 527.9 K to 477.9 K (-9.47 %) |
| Aug 24 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 3.63 | 118,671 | 430,776 | 118,671 | |
| Aug 24 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 25,826 | 0 | 527,934 | 502.1 K to 527.9 K (+5.14 %) |
| Jul 08 2019 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
| Jan 09 2019 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | CEO | Sell | D | 0.00 | 123,449 | 0 | 502,108 | 625.6 K to 502.1 K (-19.73 %) |
| Dec 28 2018 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | CEO | Sell | D | 0.00 | 627,228 | 0 | 625,557 | 1.3 M to 625.6 K (-50.07 %) |
| Jun 12 2018 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | CEO | Option Exercise | A | 2.94 | 1,922,100 | 5,650,974 | 1,922,100 | |
| Dec 19 2017 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | CEO | Sell | D | 0.00 | 151,678 | 0 | 1,252,785 | 1.4 M to 1.3 M (-10.80 %) |
| Mar 07 2017 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | President, CEO | Grant | A | 2.04 | 588,235 | 1,199,999 | 1,404,463 | 816.2 K to 1.4 M (+72.07 %) |
| Dec 15 2016 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | President, CEO | Sell | D | 0.00 | 5,168 | 0 | 816,228 | 821.4 K to 816.2 K (-0.63 %) |
| Jan 28 2016 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | President, CEO | Grant | A | 3.22 | 403,727 | 1,300,001 | 821,396 | 417.7 K to 821.4 K (+96.66 %) |
Page: 1